Intratumoral immunotherapy using platelet-cloaked nanoparticles enhances antitumor immunity in solid tumors

Intratumoral immunotherapy is an emerging modality for the treatment of solid tumors. Toll-like receptor (TLR) agonists have shown promise for eliciting immune responses, but systemic administration often results in the development of adverse side effects. Herein, we investigate whether localized de...

Descripción completa

Detalles Bibliográficos
Autores principales: Bahmani, Baharak, Gong, Hua, Luk, Brian T., Haushalter, Kristofer J., DeTeresa, Ethel, Previti, Mark, Zhou, Jiarong, Gao, Weiwei, Bui, Jack D., Zhang, Liangfang, Fang, Ronnie H., Zhang, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012593/
https://www.ncbi.nlm.nih.gov/pubmed/33790276
http://dx.doi.org/10.1038/s41467-021-22311-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012593/
https://www.ncbi.nlm.nih.gov/pubmed/33790276
http://dx.doi.org/10.1038/s41467-021-22311-z

Ejemplares similares